FDC launches Favipiravir oral suspension to treat COVID-19 in India

In order to combat COVID-19, we believe in offering best efficacy along with convenience to our patients and as such we have focused our efforts in making the process of COVID-19 treatment hassle-free," FDC Business Development& Commercial Excellence General Manager Mayank Tikkha said.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news